V Britain became the first country in the world to approve an antiviral oral pill against COVID-19, developed jointly by Merck and Ridgeback Biotherapeutics, on Thursday, which would give a new impetus to the fight against the pandemic. BNR.
The UK Medicines and Health Products Regulatory Agency (MHRA) has recommended that molnupiravir be used as soon as possible after a positive COVID-19 test and within five days of the onset of symptoms.
Health Service (NHS) will confirm how this Covid-19 treatment will be provided to patients in a timely manner.
Merck said it expects to produce 10 million courses of this treatment by the end of this year, with at least 20 million courses of treatment to be produced in 2022.
The company also issued a statement explaining that the UK’s Medicines and Health Products Regulatory Agency (MHRA) has approved the use of the drug to ‘treat mild to moderate COVID-19 in adults with a positive test and with’ at least one risk factor in the development of severe disease “.
